Archived Story

In Covid-19 crisis, India reports 350K new cases on Saturday

primary article image

PermaLink

Manveena Suri

CNN


Top News

Singapore Covid cases re-surge, government tightens restrictions, business impact looming

primary article image

PermaLink

Dewey Sim

South China Morning Post

Related: cruiseindustrynews, CNBC

Businesses fathom and cautionly react to CDC's de-mask guidelines

primary article image

PermaLink

Megan Cerullo

CBS News

Related: WISN, Crain's Detroit Business

Study found delaying the 2nd shot of the BioNTech-Pfizer mRNA vaccine from 3-week to 12-week boosts peak antibody levels for 3.5X

primary article image

PermaLink

Heidi Ledford

Nature

Related: Reuters

New CDC mask guidance likely to encourage more Americans to get Covid vaccine

primary article image

PermaLink

Kevin Stankiewicz

CNBC


US supports wavering patent for COVID-19 vaccines. Shares of key Covid vaccine makers drop sharply

primary article image

PermaLink

Amanda Macias

CNBC

Related: Nature, STAT, @AmbassadorTai

Opinion: COVID vaccines: time to confront anti-vax aggression - Halting the spread of the coronavirus will require a high-level counteroffensive against new destructive forces

primary article image

PermaLink

Peter Hotez

Nature

Related: @EricTopol

In Covid-19 crisis, India reports 350K new cases on Saturday

primary article image

PermaLink

Manveena Suri

CNN


India experiencing ‘tsunami’ of COVID-19 cases, with one COVID-19 death in every four minutes in its capital city Delhi

primary article image

PermaLink

Nilanjana Bhowmick

National Geographic

Related: Reuters

FDA and CDC lift pause on J&J Covid vaccine, may add a warning about the risk of very rare but severe blood clots to the label

primary article image

PermaLink

US FDA

YouTube

Related: NBC

CDC advisors meet today to consider whether or not to resume rollout of Johnson & Johnson's COVID-19 vaccine, while investigating two new blood clotting incidents: a death in Oregon and a hospitalization in Texas

primary article image

PermaLink

Kanishka Singh

Reuters


FDA pauses J&J’s Covid-19 vaccine due to rare blood clotting events in six women. FDA: "As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S."

primary article image

PermaLink

Berkeley Lovelace Jr.

CNBC

Related: @US_FDA, US FDA

Delay in Australia COVID-19 vaccination rollout after AstraZeneca shots restricted to 50 years and older (due to risk of rare cases of blood clots), while people under the age of 50 to take Pfizer’s COVID-19 vaccine

primary article image

PermaLink

Paulina Duran

Reuters


Regeneron's COVID-19 antibody cocktail shown to prevent symptomatic infections in people exposed to Covid-19 patients, with 72% protection during the first week and 93% protection after that. The Company to seek FDA approval for prevention

primary article image

PermaLink

Squawk Box

YouTube

Related: yahoo, CNBC

CNBC: Why Covid vaccinated people still need to take protective measures: takes time to reach full immunity, “breakthrough case”, vaccine less effective on Covid variants

primary article image

PermaLink

Cory Stieg

CNBC


Pfizer & BioNTech update on their Covid vaccine: 91.3% effective for 6 months in preventing symptomatic cases, 95.3% - 100% effective in preventing severe disease, 100% effective in preventing South Africa variant

primary article image

PermaLink

Reuters Staff

CNBC

Related: pfizer

Pfizer & BioNTech say their Covid-19 vaccine showed 100% efficacy and no major safety issues in youths ages 12 to 15 in a phase 3 clinical trial of 2,260 participants

primary article image

PermaLink

Lauren Mascarenhas

CNN

Related: BioNTech, POLITICO

Insider interview: BioNTech Co-founders Özlem Türeci and Ugur Sahin on developing COVID-19 vaccine, mRNA technology for cancer treatment, European vaccine rollout, life, and much more

primary article image

PermaLink

Mathias Döpfner

Business Insider


NIAID: "AstraZeneca may have included outdated information (Covid vaccine trial) ... may have provided an incomplete view of the efficacy data" AstraZeneca: "the primary analysis and the results were consistent with the interim analysis"

primary article image

PermaLink

Sam Meredith

CNBC

Related: ABC News, AstraZeneca

Oxford-AstraZeneca Covid vaccine shown 79% efficacy in its 32,000-people US study, 100% effective against severe or critical symptomatic disease, no serious safety issues observed. The Company to file for FDA approval

primary article image

PermaLink

Staff Writer

ox

Related: The Hill, STAT, New York Times

European Medicines Agency: Oxford-AstraZeneca COVID vaccine is "safe and effective". Italy and Germany to restart rolling out this vaccine

primary article image

PermaLink

Staff Writer

euronews

Related: Neue Zürcher Zeitung, zdf, Süddeutsche.de, NPR - National Public Radio

Latest News

Vaccinated Americans have CDC's OK to de-mask. Businesses say not so fast.

14 May 2021, 8:05 PM, Megan Cerullo, CBS News


Delaying a COVID vaccine’s second dose boosts immune response

14 May 2021, 7:27 PM, Heidi Ledford, Nature


Singapore-Cruising Operators React to Government’s COVID-19 Alert

14 May 2021, 11:19 AM, Maria Romanenko, cruiseindustrynews


New CDC mask guidelines shock businesses, city

14 May 2021, 3:55 AM, Courtney Sisk, WISN


CDC's U-turn on mask-wearing puts businesses in a bind

14 May 2021, 12:35 AM, Richard Clough, Crain's Detroit Business


Singapore stocks slump as Covid restrictions tighten, travel bubble with Hong Kong likely delayed

14 May 2021, Yen Nee Lee, CNBC


New CDC mask guidance may spur more Americans to get Covid vaccine, says Dr. Scott Gottlieb

14 May 2021, Kevin Stankiewicz, CNBC


Singapore reports 24 Covid-19 cases, but Hong Kong says travel bubble still on

13 May 2021, 10:31 AM, Dewey Sim, South China Morning Post


Delayed second Pfizer COVID-19 shot produces more antibodies -study

13 May 2021, Alistair Smout, Reuters


In shock move, US backs waiving patents on COVID vaccines

06 May 2021, 1:40 PM, Amy Maxmen, Nature


Waiver of patent rights on Covid vaccines may be mostly symbolic, for now

06 May 2021, Damian Garde, STAT


U.S. backs waiving patent protections for Covid vaccines, citing global health crisis

05 May 2021, Amanda Macias, CNBC


COVID vaccines: time to confront anti-vax aggression

27 Apr 2021, 1:30 PM, Peter Hotez, Nature


India sets Covid-19 infection record for fourth straight day with hospitals desperate for oxygen

25 Apr 2021, Manveena Suri, CNN


How India’s second wave became the worst COVID-19 surge in the world

24 Apr 2021, 3:10 PM, Nilanjana Bhowmick, National Geographic


FDA and CDC Virtual Press Conference: Johnson & Johnson COVID-19 Vaccine

24 Apr 2021, 3:47 AM, US FDA, YouTube


FDA, CDC lift pause on J&J Covid vaccinations

24 Apr 2021, 12:15 AM, Sara G. Miller, NBC


Indian hospitals turn away patients in COVID-19 ‘tsunami’

24 Apr 2021, Sanjeev Miglani Manoj Kumar, Reuters


U.S. CDC probes new death, hospitalization after J&J vaccine shots - officials

23 Apr 2021, Kanishka Singh, Reuters


CDC vaccine advisers to hear about new blood clot cases linked with J&J coronavirus vaccine

22 Apr 2021, Maggie Fox, CNN